Genetec Technology Berhad Management
Management criteria checks 1/4
Genetec Technology Berhad's CEO is Kem Chin, appointed in Oct 1997, has a tenure of 28.08 years. total yearly compensation is MYR4.67M, comprised of 17.6% salary and 82.4% bonuses, including company stock and options. directly owns 7.76% of the company’s shares, worth MYR17.99M. The average tenure of the management team and the board of directors is 0.3 years and 3.7 years respectively.
Key information
Kem Chin
Chief executive officer
RM 4.7m
Total compensation
| CEO salary percentage | 17.62% |
| CEO tenure | 28.1yrs |
| CEO ownership | 7.8% |
| Management average tenure | less than a year |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Genetec Technology Berhad (KLSE:GENETEC) Might Not Be As Mispriced As It Looks After Plunging 26%
Nov 04
Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Oct 15Genetec Technology Berhad (KLSE:GENETEC) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 02We Like These Underlying Return On Capital Trends At Genetec Technology Berhad (KLSE:GENETEC)
Aug 26Calculating The Intrinsic Value Of Genetec Technology Berhad (KLSE:GENETEC)
Jul 22Genetec Technology Berhad (KLSE:GENETEC) Shareholders Will Want The ROCE Trajectory To Continue
May 14It's Down 27% But Genetec Technology Berhad (KLSE:GENETEC) Could Be Riskier Than It Looks
Mar 09Need To Know: Analysts Are Much More Bullish On Genetec Technology Berhad (KLSE:GENETEC) Revenues
Feb 13Genetec Technology Berhad (KLSE:GENETEC) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Jan 22Genetec Technology Berhad (KLSE:GENETEC) Shares Fly 25% But Investors Aren't Buying For Growth
Dec 08Analysts Just Shaved Their Genetec Technology Berhad (KLSE:GENETEC) Forecasts Dramatically
Dec 03Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Nov 28Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 23Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Sep 22Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be
Aug 27Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%
Aug 19Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Aug 06Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable
Feb 26Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement
Jan 15Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders
Sep 22Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?
Feb 08Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency
Dec 28Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?
Nov 17Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital
Aug 16Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet
Jul 21Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -RM 78m |
| Jun 30 2025 | RM 5m | RM 822k | -RM 31m |
| Jun 30 2024 | RM 994k | RM 1m | RM 69m |
| Mar 31 2024 | n/a | n/a | RM 76m |
| Dec 31 2023 | n/a | n/a | RM 69m |
| Sep 30 2023 | n/a | n/a | RM 59m |
| Jun 30 2023 | n/a | n/a | RM 66m |
| Mar 31 2023 | RM 965k | RM 829k | RM 50m |
| Dec 31 2022 | n/a | n/a | RM 70m |
| Sep 30 2022 | n/a | n/a | RM 75m |
| Jun 30 2022 | n/a | n/a | RM 67m |
| Mar 31 2022 | RM 952k | RM 827k | RM 56m |
| Dec 31 2021 | n/a | n/a | RM 37m |
| Sep 30 2021 | n/a | n/a | RM 20m |
| Jun 30 2021 | n/a | n/a | RM 6m |
| Mar 31 2021 | RM 947k | RM 821k | -RM 4m |
| Dec 31 2020 | n/a | n/a | -RM 6m |
| Sep 30 2020 | n/a | n/a | RM 1m |
| Jun 30 2020 | n/a | n/a | -RM 1m |
| Mar 31 2020 | RM 1m | RM 840k | -RM 166k |
| Dec 31 2019 | n/a | n/a | RM 4m |
| Sep 30 2019 | n/a | n/a | RM 469k |
| Jun 30 2019 | n/a | n/a | RM 981k |
| Mar 31 2019 | RM 1m | RM 851k | RM 6m |
Compensation vs Market: Kem's total compensation ($USD1.13M) is above average for companies of similar size in the MY market ($USD112.54K).
Compensation vs Earnings: Kem's compensation has increased whilst the company is unprofitable.
CEO
Kem Chin (55 yo)
Mr. Kem Weng Chin is Chief Executive Officer of Genetec Technology Berhad since August 28, 2025 He served as the Managing Director of Genetec Technology Berhad since October 27, 1997 until August 28, 2025...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 28.1yrs | RM 4.67m | 7.76% MYR 18.0m | |
| Deputy CEO & Executive Director | less than a year | RM 4.20m | 1.76% MYR 4.1m | |
| Chief Financial Officer | 16.1yrs | no data | 1.82% MYR 4.2m | |
| Senior Vice President of Business Development | less than a year | no data | no data | |
| Senior Vice President of Strategic Operations & Corporate Affairs | less than a year | no data | no data | |
| Senior Vice President of Corporate & Operations Finance | less than a year | no data | no data | |
| Company Secretary | 15.1yrs | no data | no data |
Experienced Management: GENETEC's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | no data | RM 4.67m | 7.76% MYR 18.0m | |
| Deputy CEO & Executive Director | 7.1yrs | RM 4.20m | 1.76% MYR 4.1m | |
| Independent Non-Executive Director | 5.3yrs | RM 120.00k | 0.11% MYR 260.4k | |
| Independent Non-Executive Director | 3.7yrs | RM 72.00k | 0.013% MYR 30.0k | |
| Independent Non-Executive Director | 2.1yrs | RM 72.00k | no data | |
| Independent Non-Executive Chairman | 2.5yrs | RM 144.00k | 0.52% MYR 1.2m |
Experienced Board: GENETEC's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/30 03:01 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genetec Technology Berhad is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhen Ye Khoo | CLSA |
| null null | Mercury Securities Sdn. Bhd |